MERLION PHARMACEUTICALS PTE LTD ANNOUNCES THE COMPLETION OF MERGER WITH COMBINATURE BIOPHARM AG AND ATHELAS SA

MerLion Pharmaceuticals Pte Ltd (MerLion) of Singapore, the world's leading natural products-based drug discovery company, announces that it has completed a merger by exchange of shares with Combinature Biopharm AG (Berlin, Germany) and Athelas SA (Geneva, Switzerland). Both European companies become 100% subsidiaries of MerLion, whose headquarters and drug discovery research centre is based in Singapore. Drug development of its anti-infective programmes and nuclear magnetic resonance screening activities will be conducted from Berlin. BioSpace (http://www.biospace.com/news_story.aspx?StoryID=27963&full=1)